Simplifying and standardizing global post-marketing studies! Accelerating continuous innovation.
This product is an application that simplifies and standardizes post-market surveillance of medical devices, improving the safety, reliability, and quality of the products. Rapid reporting of adverse events is ensured through fully automated electronic reporting to authorities and the output of written submission documents. Seamless integration with quality and regulatory processes enables proactive complaint handling throughout the entire product lifecycle, accelerating continuous innovation. 【Features】 ■ Global reporting obligation determination tree ■ Reporting deadline management ■ Automated adverse event reporting ■ Interactive dashboard and reports ■ Customizable adverse event management workflow ■ Part of Veeva Vault Quality Suite *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
**Merits** - Improved product quality and patient safety - Proactively identify and resolve product quality issues to enhance reliability, safety, and compliance. - Compliance with submission deadlines - Intelligent global reporting obligation decision trees that accommodate country-specific standards to ensure adherence to reporting deadlines. - Real-time visibility and end-to-end control - Achieve information-based business decision-making by visualizing reporting and complaint handling standards in real-time. *For more details, please refer to the PDF document or feel free to contact us.*
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Veeva's industry cloud solutions provide data, software, services, and a broad ecosystem of partners to support our customers' critical functions, from R&D to commercial. We help companies of various sizes bring products to market more quickly and efficiently while maintaining compliance.